Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: Journal of Pharmacy and Pharmaceutical Sciences)
Source: Journal of Pharmacy and Pharmaceutical Sciences - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
CONCLUSION: SGLT2 inhibitors have antiproliferation, anti-tumorigenesis, and anti-migration effects and may induce apoptosis in cancer cells. In addition, treatment with SGLT2 inhibitors resulted in the downregulation of selected genes in the Du-145 cell line.PMID:35977549 | DOI:10.18433/jpps32879 (Source: J Pharm Pharm Sci)
Source: J Pharm Pharm Sci - August 17, 2022 Category: Drugs & Pharmacology Authors: Sanaa Bardaweel Ahmad Issa Source Type: research
